Harvard Health Letter
More antidotes for newer blood thinners
New medications add advantages to treatments that help prevent stroke, pulmonary embolism, and deep-vein thrombosis. The wait is over for an antidote to stop rare uncontrolled bleeding linked to some newer blood thinners. The FDA approved andexanet alfa (AndexXa) on May 3, 2018. Itís the first and only antidote to reverse bleeding in people taking apixaban (Eliquis), rivaroxaban (Xarelto), or edoxaban (Savaysa).